Selenoneine is a major selenium species in beluga skin and red blood cells of Inuit from Nunavik.


Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 27 01 2019
revised: 17 04 2019
accepted: 24 04 2019
pubmed: 18 5 2019
medline: 6 8 2019
entrez: 18 5 2019
Statut: ppublish

Résumé

Nunavimmiut (Inuit of Nunavik, Northern Quebec, Canada) exhibit a high selenium (Se) status because of their frequent consumption of marine mammal foods. Indirect evidence from our previous studies had suggested that selenoneine - a novel selenocompound - may be accumulating in the blood of Nunavimmiut. We used a liquid-chromatography/inductively coupled tandem mass spectrometry (LC-ICP-MS/MS) method to measure concentrations of selenoneine and its methylated metabolite Se-methylselenoneine in archived red blood cells (RBC) obtained from 210 Nunavimmiut living in communities along the Hudson Strait, where marine mammal hunting and consumption are most frequent in Nunavik. This method was adapted to quantify selenoneine and its methylated metabolite in beluga mattaaq, an Inuit delicacy consisting of the skin with the underlying layer of fat and the major dietary source of Se for Nunavimmiut. Total selenium concentration was also measured in RBC and beluga mattaaq samples by isotope dilution ICP-MS/MS. The median selenoneine concentration in RBC was 413 μg Se/L (range = 3.20-3230 μg Se/L), representing 54% (median) of total Se content (range = 1.6-91%). Quantification of selenoneine in five beluga mattaaq samples (skin layer) from Nunavik revealed a median concentration of 1.8 μg Se/g wet wt (range = 1.2-7.4 μg Se/g), constituting 54% (median) of the total Se content (range = 44-74%). Se-methylselenoneine was also detected in Inuit RBC but not in beluga mattaaq, suggesting that selenoneine undergoes methylation in humans. Selenoneine may protect Nunavimmiut from methylmecury toxicity by increasing its demethylation in RBC and in turn decreasing its distribution to target organs.

Identifiants

pubmed: 31100626
pii: S0045-6535(19)30854-9
doi: 10.1016/j.chemosphere.2019.04.191
pii:
doi:

Substances chimiques

Organoselenium Compounds 0
Se-methylselenoneine 0
selenoneine 0
Histidine 4QD397987E
Selenium H6241UJ22B

Types de publication

Journal Article

Langues

eng

Pagination

549-558

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Adel Achouba (A)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital du Saint-Sacrement, 1050, Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.

Pierre Dumas (P)

Centre de Toxicologie du Québec, Institut national de santé publique du Québec (INSPQ), 945 Wolfe, Québec, QC, G1V 5B3, Canada.

Nathalie Ouellet (N)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital du Saint-Sacrement, 1050, Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.

Matthew Little (M)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital du Saint-Sacrement, 1050, Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada.

Mélanie Lemire (M)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital du Saint-Sacrement, 1050, Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada; Département de médecine préventive et sociale, Université Laval, Pavillon Ferdinand-Vandry, Québec, QC, G1V 0A6, Canada.

Pierre Ayotte (P)

Axe Santé des populations et pratiques optimales en santé, Centre de recherche du CHU de Québec, Hôpital du Saint-Sacrement, 1050, Chemin Sainte-Foy, Québec, QC, G1S 4L8, Canada; Centre de Toxicologie du Québec, Institut national de santé publique du Québec (INSPQ), 945 Wolfe, Québec, QC, G1V 5B3, Canada; Département de médecine préventive et sociale, Université Laval, Pavillon Ferdinand-Vandry, Québec, QC, G1V 0A6, Canada. Electronic address: pierre.ayotte@inspq.qc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH